Cargando…

Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury

The use of mesenchymal stromal cell (MSC) transplantation to repair the injured spinal cord has shown consistent benefits in preclinical models. However, the low survival rate of grafted MSC is one of the most important problems. In the injured spinal cord, transplanted cells are exposed to hypoxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Ai, Nakajima, Hideaki, Uchida, Kenzo, Takeura, Naoto, Honjoh, Kazuya, Watanabe, Shuji, Kitade, Makoto, Kokubo, Yasuo, Johnson, William E. B., Matsumine, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158550/
https://www.ncbi.nlm.nih.gov/pubmed/29947256
http://dx.doi.org/10.1177/0963689718780309
_version_ 1783358440798683136
author Takahashi, Ai
Nakajima, Hideaki
Uchida, Kenzo
Takeura, Naoto
Honjoh, Kazuya
Watanabe, Shuji
Kitade, Makoto
Kokubo, Yasuo
Johnson, William E. B.
Matsumine, Akihiko
author_facet Takahashi, Ai
Nakajima, Hideaki
Uchida, Kenzo
Takeura, Naoto
Honjoh, Kazuya
Watanabe, Shuji
Kitade, Makoto
Kokubo, Yasuo
Johnson, William E. B.
Matsumine, Akihiko
author_sort Takahashi, Ai
collection PubMed
description The use of mesenchymal stromal cell (MSC) transplantation to repair the injured spinal cord has shown consistent benefits in preclinical models. However, the low survival rate of grafted MSC is one of the most important problems. In the injured spinal cord, transplanted cells are exposed to hypoxic conditions and exposed to nutritional deficiency caused by poor vascular supply. Also, the transplanted MSCs face cytotoxic stressors that cause cell death. The aim of this study was to compare adipose-derived MSCs (AD-MSCs) and bone marrow-derived MSCs (BM-MSCs) isolated from individual C57BL6/J mice in relation to: (i) cellular characteristics, (ii) tolerance to hypoxia, oxidative stress and serum-free conditions, and (iii) cellular survival rates after transplantation. AD-MSCs and BM-MSCs exhibited a similar cell surface marker profile, but expressed different levels of growth factors and cytokines. To research their relative stress tolerance, both types of stromal cells were incubated at 20.5% O(2) or 1.0% O(2) for 7 days. Results showed that AD-MSCs were more proliferative with greater culture viability under these hypoxic conditions than BM-MSCs. The MSCs were also incubated under H(2)O(2)-induced oxidative stress and in serum-free culture medium to induce stress. AD-MSCs were better able to tolerate these stress conditions than BM-MSCs; similarly when transplanted into the spinal cord injury region in vivo, AD-MSCs demonstrated a higher survival rate post transplantation Furthermore, this increased AD-MSC survival post transplantation was associated with preservation of axons and enhanced vascularization, as delineated by increases in anti-gamma isotype of protein kinase C and CD31 immunoreactivity, compared with the BM-MSC transplanted group. Hence, our results indicate that AD-MSCs are an attractive alternative to BM-MSCs for the treatment of severe spinal cord injury. However, it should be noted that the motor function was equally improved following moderate spinal cord injury in both groups, but with no significant improvement seen unfortunately following severe spinal cord injury in either group.
format Online
Article
Text
id pubmed-6158550
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-61585502018-10-01 Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury Takahashi, Ai Nakajima, Hideaki Uchida, Kenzo Takeura, Naoto Honjoh, Kazuya Watanabe, Shuji Kitade, Makoto Kokubo, Yasuo Johnson, William E. B. Matsumine, Akihiko Cell Transplant Original Articles The use of mesenchymal stromal cell (MSC) transplantation to repair the injured spinal cord has shown consistent benefits in preclinical models. However, the low survival rate of grafted MSC is one of the most important problems. In the injured spinal cord, transplanted cells are exposed to hypoxic conditions and exposed to nutritional deficiency caused by poor vascular supply. Also, the transplanted MSCs face cytotoxic stressors that cause cell death. The aim of this study was to compare adipose-derived MSCs (AD-MSCs) and bone marrow-derived MSCs (BM-MSCs) isolated from individual C57BL6/J mice in relation to: (i) cellular characteristics, (ii) tolerance to hypoxia, oxidative stress and serum-free conditions, and (iii) cellular survival rates after transplantation. AD-MSCs and BM-MSCs exhibited a similar cell surface marker profile, but expressed different levels of growth factors and cytokines. To research their relative stress tolerance, both types of stromal cells were incubated at 20.5% O(2) or 1.0% O(2) for 7 days. Results showed that AD-MSCs were more proliferative with greater culture viability under these hypoxic conditions than BM-MSCs. The MSCs were also incubated under H(2)O(2)-induced oxidative stress and in serum-free culture medium to induce stress. AD-MSCs were better able to tolerate these stress conditions than BM-MSCs; similarly when transplanted into the spinal cord injury region in vivo, AD-MSCs demonstrated a higher survival rate post transplantation Furthermore, this increased AD-MSC survival post transplantation was associated with preservation of axons and enhanced vascularization, as delineated by increases in anti-gamma isotype of protein kinase C and CD31 immunoreactivity, compared with the BM-MSC transplanted group. Hence, our results indicate that AD-MSCs are an attractive alternative to BM-MSCs for the treatment of severe spinal cord injury. However, it should be noted that the motor function was equally improved following moderate spinal cord injury in both groups, but with no significant improvement seen unfortunately following severe spinal cord injury in either group. SAGE Publications 2018-06-27 2018-07 /pmc/articles/PMC6158550/ /pubmed/29947256 http://dx.doi.org/10.1177/0963689718780309 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Takahashi, Ai
Nakajima, Hideaki
Uchida, Kenzo
Takeura, Naoto
Honjoh, Kazuya
Watanabe, Shuji
Kitade, Makoto
Kokubo, Yasuo
Johnson, William E. B.
Matsumine, Akihiko
Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury
title Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury
title_full Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury
title_fullStr Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury
title_full_unstemmed Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury
title_short Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury
title_sort comparison of mesenchymal stromal cells isolated from murine adipose tissue and bone marrow in the treatment of spinal cord injury
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158550/
https://www.ncbi.nlm.nih.gov/pubmed/29947256
http://dx.doi.org/10.1177/0963689718780309
work_keys_str_mv AT takahashiai comparisonofmesenchymalstromalcellsisolatedfrommurineadiposetissueandbonemarrowinthetreatmentofspinalcordinjury
AT nakajimahideaki comparisonofmesenchymalstromalcellsisolatedfrommurineadiposetissueandbonemarrowinthetreatmentofspinalcordinjury
AT uchidakenzo comparisonofmesenchymalstromalcellsisolatedfrommurineadiposetissueandbonemarrowinthetreatmentofspinalcordinjury
AT takeuranaoto comparisonofmesenchymalstromalcellsisolatedfrommurineadiposetissueandbonemarrowinthetreatmentofspinalcordinjury
AT honjohkazuya comparisonofmesenchymalstromalcellsisolatedfrommurineadiposetissueandbonemarrowinthetreatmentofspinalcordinjury
AT watanabeshuji comparisonofmesenchymalstromalcellsisolatedfrommurineadiposetissueandbonemarrowinthetreatmentofspinalcordinjury
AT kitademakoto comparisonofmesenchymalstromalcellsisolatedfrommurineadiposetissueandbonemarrowinthetreatmentofspinalcordinjury
AT kokuboyasuo comparisonofmesenchymalstromalcellsisolatedfrommurineadiposetissueandbonemarrowinthetreatmentofspinalcordinjury
AT johnsonwilliameb comparisonofmesenchymalstromalcellsisolatedfrommurineadiposetissueandbonemarrowinthetreatmentofspinalcordinjury
AT matsumineakihiko comparisonofmesenchymalstromalcellsisolatedfrommurineadiposetissueandbonemarrowinthetreatmentofspinalcordinjury